PIGB
protein-codingphosphatidylinositol glycan anchor biosynthesis class B, the group of Dolichyl D-mannosyl phosphate dependent mannosyltransferases|Phosphatidylinositol glycan anchor biosynthesis
Gene summary
This gene encodes a transmembrane protein that is located in the endoplasmic reticulum and is involved in GPI-anchor biosynthesis. The glycosylphosphatidylinositol (GPI) anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene is thought to encode a member of a family of dolichol-phosphate-mannose (Dol-P-Man) dependent mannosyltransferases. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0032822
Submitter: ClinGen
*PIGB* was first reported in related to DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80 (MONDO:0032822) in 1996 (Takahashi et al., 1996, PMID:8861954). DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80 is an autosomal recessive neurologic disorder characterized by the onset of refractory seizures in the first year of life. Patients have severe global developmental delay and may have additional variable features, including dysmorphic or coarse facial features, distal skeletal abnormalities, and impaired hearing or vision. At the cellular level, the disorder is caused by a defect in the synthesis of glycosylphosphatidylinositol (GPI) and thus affects the expression of GPI-anchored proteins at the cell surface (summary by Murakami et al., 2019). The *PIGB* gene encodes a transmembrane protein that is located in the endoplasmic reticulum and is involved in GPI-anchor biosynthesis. The GPI anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene is thought to encode a member of a family of dolichol-phosphate-mannose (Dol-P-Man) dependent mannosyltransferases. [provided by RefSeq, Jul 2008]. More than 350 unique variants (e.g., frameshift, missense, in-frame indel, nonsense and splice sites) have been reported in humans by ClinVar. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Ten variants that have been reported in 8 probands in 1 publication (Murakami et al., 2019; PMID: 31256876), are included in this curation. A model system that describes restored function of the GPI anchor synthesis pathway in a mutant mouse cell line (Takahashi et al., 1996, PMID:8861954) also supports this gene-disease relationship. In summary, there is moderate evidence to support *PIGB* in association with DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 80. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on meeting date December 5, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0032822
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0032822
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0032822
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0032822
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PIGB variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004855.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 99 | 102 | |||
| missense | 2 | 4 | 150 | 8 | 4 | 168 |
| nonsense | 12 | 2 | 1 | 15 | ||
| start loss | 0 | |||||
| frameshift | 6 | 1 | 3 | 10 | ||
| splice donor/acceptor (+/-2bp) | 6 | 4 | 10 | |||
| Total | 20 | 13 | 161 | 107 | 4 | 305 |
Highest pathogenic variant AF is 0.000135318
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004846.4 | 12 | MANE Select | |
| Ensembl | ENSP00000164305.5 | 12 | MANE Select | |
| Ensembl | ENSP00000438963.2 | 12 | Standard | |
| Ensembl | ENSP00000455943.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Glycosylphosphatidylinositol (GPI)-anchor biosynthesis - Homo sapiens (human)
- Synthesis of glycosylphosphatidylinositol (GPI)
- Post-translational modification: synthesis of GPI-anchored proteins
- Post-translational protein modification
- Metabolism of proteins
Biological Process
- GPI anchor biosynthetic process
- preassembly of GPI anchor in ER membrane
- mannosylation
Molecular Function
- mannosyltransferase activity
- glycolipid mannosyltransferase activity
Cellular Component
- endoplasmic reticulum
- endoplasmic reticulum membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000164305
- Coding exons
- 12
- Length
- 36689
- Individuals with no LoFs
- 124611
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 42
- Defined
- 124653
- p
- 0.000168
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.595 | 239 | 266 | 0.897 | 0.0000126 | 3617 |
| Missense (PolyPhen) | 71 | 91.54 | 0.77562 | 1246 | ||
| Synonymous | 0.295 | 88 | 91.6 | 0.961 | 0.00000420 | 1015 |
| Loss of Function | 1.30 | 20 | 27.3 | 0.732 | 0.00000135 | 364 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00045 | 0.00045 | rare |
| Latino/Admixed American | 0.00019 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00040 | 0.00039 | rare |
| Finnish | 0.000047 | 0.000046 | rare |
| European (Non-Finnish) | 0.00016 | 0.00015 | rare |
| South Asian | 0.000099 | 0.000098 | rare |
| Other | 0.00018 | 0.00017 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Mannosyltransferase involved in glycosylphosphatidylinositol-anchor biosynthesis. Transfers the third alpha-1,2-mannose to Man2-GlcN-acyl-PI during GPI precursor assembly. {ECO:0000269|PubMed:8861954}.;
Recessive Scores
- pRec
- 0.0985
Essentials
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.302
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |